The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.
This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.
Arnt Kristen studied medicine at the Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany, obtaining his MD degree in 2001. He completed his residency in internal medicine at the Department of Internal Medicine, University Hospital, Heidelberg, Germany. He received board certifications for internal medicine and cardiology in 2008 and 2010, respectively. He received a degree in business administration in 2008. Prof. Dr. Kristen currently works as a cardiologist at the Heidelberg Heart Centre and Heidelberg Amyloidosis Centre at the University of Heidelberg and at the Cardiovascular Centre Darmstadt.
Prof. Dr. Kristen’s scientific and clinical focus is on cardiomyopathies and rare diseases, as well as the management and treatment of these disorders, including heart transplantation. His particular emphasis is on cardiac amyloidosis, and another clinical interest is the field of interventional cardiology.
Prof. Dr. Kristen is a member of the German Society of Cardiology and the German Society for Amyloid Diseases. He is an investigator in several clinical trials focused on the treatment of hereditary amyloidosis. Moreover, he served as a consultant for cardiac amyloidosis and is author of more than 50 peer-reviewed publications in national and international journals with focus on cardiac amyloidosis.